期刊文献+

哺乳动物雷帕霉素靶蛋白信号传导与恶性肿瘤的治疗 被引量:2

下载PDF
导出
出处 《临床泌尿外科杂志》 2003年第8期500-502,共3页 Journal of Clinical Urology
  • 相关文献

参考文献13

  • 1Schmelzle T, Hall M N. TOR, a central controller of cell growth. Cell, 2000,103 : 253-- 262.
  • 2Raught B, Gingras A C, Sonenberg N . The target of rapamycin (TOR) proteins. PNAS, 2001, 98.. 7037 --7044.
  • 3Hashemolhosseini S, Nagamine Y , Morlay S J, et al.Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclinD1 mRNA and Protein Stability,J Biol Chem, 1998,273 : 14424-- 14429.
  • 4Hosoi H, Diling M B, Shikata T ,et al. Rapamycin causes poorly reversible inhibition of mTOR and induces p53 independent apoptosis in human rhabdomyosracomacells. Cancer Res, 1999,59 : 886-- 894.
  • 5Guba M, Breitenbuch P V, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis involvement of vascular endothelial growth factor. Nature Medicine, 2002,8 : 128-- 135.
  • 6Sekulic A, Hudson C C, Homme J L, et al. A direct Linkage between the Phospoinositide 3-Kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res,2000,60:3504--3513.
  • 7Jensen P B , Hunter T. Oncogenic kinase signalling .Nature, 2001,411:355--365.
  • 8Shah S A, Michael M D, Potter W, et al. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation. J Surg Res,2001,97:123--130.
  • 9Cantrell D A . Phosphoinositide 3-kinase signalling pathways. J Cell Sci, 2001,114 : 1439-- 1445.
  • 10Testa J R, Bellacosa A. Akt plays a central role in tumorigenesis. PNAS,2001,98 : 10983-- 10985.

同被引文献32

  • 1崔仑标,戴贵东,王心如.细胞周期素与膀胱癌关系的研究进展[J].中国肿瘤,2005,14(2):111-114. 被引量:3
  • 2Guba M,B reitenbuch PV,Steinbauer M,et al.Rapamycin in-hibits primary and metastasis tumor growth by antiangi ogenesis in-volvement of vascular endothelial growth factor[J].Nat Med,2002,8(4):128.
  • 3Raught B,Gingras AC,Sonenberg N.The target of rapamycin(TOR)proteins[J].RNAS,2001,98(7):7037.
  • 4Sherri CJ,Roberts JM.CDK inhibitors:Positive and negative reg-ulators of G 1-phase progression[J].Genes Dev,1999,13:1501-1512.
  • 5Abraham RT,Wiederrecht GJ.Rapamycin has a deleterious effect[J].Ann Rev Inmmunol,1996,14(3):483.
  • 6Hudson CC,Liu M,Chiang GG,et al.Regulation of hypoxia-inducible factor Ialpha expression and function by the mammalian target of rapamycin[J].Mol Cell Biol,2002,22(20):7004-7014.
  • 7Miriuka SG,Rao V,Peterson M,et al.mTOR inhibition induces endothelial progenitor cell death[J].Am J Transplant,2006,6(11):2069-2079.
  • 8Butzal M,Loges S,Schweizer M,et al.Rapamycin inhibits pro-liferation and differentiation of human endothelial progenitor cells in vitro[J].Exp Cell Res,2004,300(1):65-71.
  • 9吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 10Guba M, Breitenbuch PV, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis involvement of vascular endothelial growth factor. Nature Medicine,2002,8(4) :128.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部